Tao Li

机构：Guiyang Medical University, Affiliated Hospital of Guizhou Medical University · ORCID：0000-0002-5984-0675

发表论文 10 篇 · 总被引 43 次 · h-index 4

代表论文

• Brief Report: Ivonescimab Combined With Etoposide Plus Carboplatin as First-Line Treatment for Extensive-Stage SCLC: Results of a Phase 1b Clinical Trial (2024 · Journal of Thoracic Oncology · 被引 19)
• Prevalence of new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis (2024 · Acta Diabetologica · 被引 10)
• A review for the impacts of circadian disturbance on urological cancers (2023 · Sleep and Biological Rhythms · 被引 8)
• Prognostic significance of serum Chemerin and neutrophils levels in patients with oral squamous cell carcinoma (2024 · Heliyon · 被引 4)
• Letter to the Editor (Correspondence): Re: Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer (2025 · Laboratory Investigation · 被引 1)
• P3.01-48 The Efficiency of Low-Dose Apatinib in Treatment of Advanced Lung Squamous Cell Carcinoma (2018 · Journal of Thoracic Oncology · 被引 1)